LRIG1 and metastatic malignant neoplasm in the lymph nodes: Likewise, future retrospective and prospective studies in independent, larger cohorts will be necessary to assess whether LRIG1, either alone or in combination with other biomarkers, can reliably predict lymph node metastasis in early‐stage cervical carcinoma in a clinically meaningful way.